QIAGEN AARHUS A/S: Financial statements 2016
CVR: 28305087
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
QIAGEN AARHUS A/S (CVR 28305087) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 48,546,000 and a net result of DKK -77,775,000 compared with DKK 21,722,000 the year before. That is a decrease of 31.5% compared with the year before. Equity in the 2016 report amounted to DKK -53,606,000. The company had 100 employees in the financial year.
- Gross Profit
- DKK 48,546,000
- Profit/Loss
- DKK -77,775,000
- Equity
- DKK -53,606,000
- Total Assets
- DKK 104,609,000
- Employees
- 100
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 48.5M | -77.8M | -53.6M | 100 |
| 2015 | - | 70.9M | 21.7M | 24.2M | - |
| 2012 | - | 30M | 938K | 21.9M | 87 |
Official annual report
Find more companies like QIAGEN AARHUS A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2016
As of December 1, 2016, Jacob de Meza has joined the board of directors of QIAGEN AARHUS A/S.
As of November 30, 2016, Jacob Grydholt Jensen has left the board of directors of QIAGEN AARHUS A/S.
As of November 30, 2016, Jacob de Meza has left the board of directors of QIAGEN AARHUS A/S.
As of October 11, 2016, Laura Eldridge Furmanski is registered as director of QIAGEN AARHUS A/S.
As of October 11, 2016, Timothy Paul Grabham is registered as director of QIAGEN AARHUS A/S.
As of October 11, 2016, Kenneth Graabek Johansen has stepped down as director of QIAGEN AARHUS A/S.
As of October 11, 2016, Roald Forsberg has stepped down as director of QIAGEN AARHUS A/S.
QIAGEN AARHUS A/S has published its annual report for 2015. Gross profit came to DKK 70,853,000, and the net result was DKK 21,722,000.
About QIAGEN AARHUS A/S
QIAGEN AARHUS A/S is a Danish company of the type Aktieselskab based in Aarhus C, founded in 2004. The company is registered under the industry Computerprogrammering. The company was previously named CLC BIO A/S and GENIEMATICS A/S. The management consists of Jonas Buur Sinding and Timothy Paul Grabham. The board consists of Axel Backheuer (chair), Magnus Fellenius-Blædel, Martin Kofod Ludvigsen and Philipp Sixt Lothar von Hugo. The company is owned by Qiagen N.v.. The company has 57 employees (2026). In 2025, the company reported a gross profit of DKK 83,701,000 and a net result of DKK 4,914,000 compared with DKK 5,867,000 the year before. Equity in the 2025 report amounted to DKK 76,212,000.